Kristin Stephens
CIK: 0001865490
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Syros Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Kristin Stephens files insider reports with the SEC as Chief Development Officer of Syros Pharmaceuticals, Inc. (SYRS). Signal8 holds 3 reported Form 4/5 transactions by Kristin Stephens since Sep 2024. The most recent reported transaction is a sale (Form 4 code S) in SYRS, dated Nov 18, 2024.
About Stephens Kristin
Stephens Kristin (SEC CIK 0001865490) files insider reports with the SEC as Chief Development Officer of Syros Pharmaceuticals, Inc. (SYRS).
Signal8 holds 2 ownership filings by Stephens Kristin, all Form 4s, filed between Nov 4, 2024 and Nov 20, 2024. Those filings report 3 transactions, from Oct 31, 2024 to Nov 18, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Stephens Kristin's filings is in CAMBRIDGE, MA.
Recent filings by Stephens Kristin
Other insiders filing for Syros Pharmaceuticals, Inc. (SYRS)
- Simonian Nancy A, Director
- Roth David, Chief Medical Officer
- Quirk Gerald E, Chief Legal & Compliance Offic
- Chee Conley, President & CEO
- Haas Jason, Chief Financial Officer
- AKKARAJU SRINIVAS, Director